Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

Summary

Mim8 prophylaxis significantly reduced bleeding events in patients with or without inhibitors

Description

Mim8 prophylaxis significantly reduced bleeding events in patients with or without inhibitors

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage